187 related articles for article (PubMed ID: 8735716)
1. Expression of blood group-related antigens in cholangiocarcinoma in relation to non-neoplastic bile ducts.
Minato H; Nakanuma Y; Terada T
Histopathology; 1996 May; 28(5):411-9. PubMed ID: 8735716
[TBL] [Abstract][Full Text] [Related]
2. Expression of tenascin, type IV collagen and laminin during human intrahepatic bile duct development and in intrahepatic cholangiocarcinoma.
Terada T; Nakanuma Y
Histopathology; 1994 Aug; 25(2):143-50. PubMed ID: 7527010
[TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen and blood group-related carbohydrate antigens in glycoproteins in human bile in hepatolithiasis. Japanese Study Group of Hepatolithiasis.
Sasaki M; Morita T; Hoso M; Nakanuma Y; Tanimura H
Hepatology; 1996 Feb; 23(2):258-63. PubMed ID: 8591850
[TBL] [Abstract][Full Text] [Related]
4. Expression of apoptosis, proliferating cell nuclear antigen, and apoptosis-related antigens (bcl-2, c-myc, Fas, Lewis(y) and p53) in human cholangiocarcinomas and hepatocellular carcinomas.
Terada T; Nakanuma Y
Pathol Int; 1996 Oct; 46(10):764-70. PubMed ID: 8916146
[TBL] [Abstract][Full Text] [Related]
5. Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: correlations with cholangiocarcinoma aggressiveness.
Vasuri F; Rocchi L; Degiovanni A; Giunchi F; Brandi G; Treré D; Montanaro L; D'Errico-Grigioni A
Histopathology; 2015 Jan; 66(2):244-51. PubMed ID: 25367684
[TBL] [Abstract][Full Text] [Related]
6. S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas.
Tsai JH; Huang WC; Kuo KT; Yuan RH; Chen YL; Jeng YM
Histopathology; 2012 Dec; 61(6):1106-16. PubMed ID: 22882148
[TBL] [Abstract][Full Text] [Related]
7. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y
Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030
[TBL] [Abstract][Full Text] [Related]
8. c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma.
Terada T; Ashida K; Endo K; Horie S; Maeta H; Matsunaga Y; Takashima K; Ohta T; Kitamura Y
Histopathology; 1998 Oct; 33(4):325-31. PubMed ID: 9822921
[TBL] [Abstract][Full Text] [Related]
9. Altered mucin gene expression in stone-containing intrahepatic bile ducts and cholangiocarcinomas.
Lee KT; Liu TS
Dig Dis Sci; 2001 Oct; 46(10):2166-72. PubMed ID: 11680592
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis.
Terada T; Nakanuma Y; Sirica AE
Hum Pathol; 1998 Feb; 29(2):175-80. PubMed ID: 9490278
[TBL] [Abstract][Full Text] [Related]
11. Profiles of expression of carbohydrate chain structures during human intrahepatic bile duct development and maturation: a lectin-histochemical and immunohistochemical study.
Terada T; Nakanuma Y
Hepatology; 1994 Aug; 20(2):388-97. PubMed ID: 8045500
[TBL] [Abstract][Full Text] [Related]
12. Liver fluke-associated and sporadic cholangiocarcinoma: an immunohistochemical study of bile duct, peribiliary gland and tumour cell phenotypes.
Hughes NR; Pairojkul C; Royce SG; Clouston A; Bhathal PS
J Clin Pathol; 2006 Oct; 59(10):1073-8. PubMed ID: 16679351
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma.
Haas S; Gütgemann I; Wolff M; Fischer HP
Am J Surg Pathol; 2007 Jun; 31(6):902-6. PubMed ID: 17527078
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between clinicopathological features and CA19-9/CEA in patients with extrahepatic cholangiocarcinoma].
Tang X; Zhang J; Chen Y; Lan Z; Wang C
Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):662-6. PubMed ID: 25564055
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic acetylcholine receptor M3 in proliferation and perineural invasion of cholangiocarcinoma cells.
Feng YJ; Zhang BY; Yao RY; Lu Y
Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):418-23. PubMed ID: 22893470
[TBL] [Abstract][Full Text] [Related]
17. Regulators of apoptosis in cholangiocarcinoma.
Jhala NC; Vickers SM; Argani P; McDonald JM
Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
[TBL] [Abstract][Full Text] [Related]
18. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
19. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
Su MC; Hsu C; Kao HL; Jeng YM
Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
[TBL] [Abstract][Full Text] [Related]
20. Lectin histochemical study of cholangiocarcinoma arising from stone-bearing intrahepatic bile duct.
Lee KT; Sheen PC
J Surg Oncol; 1995 Jun; 59(2):131-5. PubMed ID: 7776654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
